Treatment of Cesarean Scar Ectopic Pregnancy with Hysteroscopic Resection.

IF 1.4 Q3 OBSTETRICS & GYNECOLOGY

Gynecology and Minimally Invasive Therapy-GMIT Pub Date : 2025-03-15 eCollection Date: 2025-04-01 DOI:10.4103/gmit.gmit_28_24

Hoora Amuzegar, Fatemeh Davari Tanha, Firoozeh Akbari Asbagh, Mahbod Ebrahimi, Sareh Ezzati, Venus Hajialiakbar

{"title":"Treatment of Cesarean Scar Ectopic Pregnancy with Hysteroscopic Resection.","authors":"Hoora Amuzegar, Fatemeh Davari Tanha, Firoozeh Akbari Asbagh, Mahbod Ebrahimi, Sareh Ezzati, Venus Hajialiakbar","doi":"10.4103/gmit.gmit_28_24","DOIUrl":null,"url":null,"abstract":"<p><p>Cesarean scar pregnancy (CSP) is an ectopic that is located in the myometrium of a previous C-section of the scar. It is rare but threatening. The aim of this study was to introduce 10 cases of CSP treated with hysteroscopic resection. In the preoperative phase, the patients with beta-human chorionic gonadotropin (B-hCG) titers more than 10,000 were treated with methotrexate (MTX) to reduce B-hCG titers. Two patients did not receive MTX. All patients were treated with hysteroscopic resection except one patient, who underwent hysteroscopic resectoscopy due to a lack of reduction of B-hCG and due to unrepairable scar site of cesarean and uterine perforation eventuate hysterectomy. All patients had normal menstrual cycles as well as the negative β-hCG level after 2 months. Moreover, no recurrence was reported after 3 years. Low-invasive treatments such as hysteroscopic resection can be an important step to maintain fertility and the general health of patients.</p>","PeriodicalId":45272,"journal":{"name":"Gynecology and Minimally Invasive Therapy-GMIT","volume":"14 2","pages":"170-173"},"PeriodicalIF":1.4000,"publicationDate":"2025-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12165682/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gynecology and Minimally Invasive Therapy-GMIT","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/gmit.gmit_28_24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Cesarean scar pregnancy (CSP) is an ectopic that is located in the myometrium of a previous C-section of the scar. It is rare but threatening. The aim of this study was to introduce 10 cases of CSP treated with hysteroscopic resection. In the preoperative phase, the patients with beta-human chorionic gonadotropin (B-hCG) titers more than 10,000 were treated with methotrexate (MTX) to reduce B-hCG titers. Two patients did not receive MTX. All patients were treated with hysteroscopic resection except one patient, who underwent hysteroscopic resectoscopy due to a lack of reduction of B-hCG and due to unrepairable scar site of cesarean and uterine perforation eventuate hysterectomy. All patients had normal menstrual cycles as well as the negative β-hCG level after 2 months. Moreover, no recurrence was reported after 3 years. Low-invasive treatments such as hysteroscopic resection can be an important step to maintain fertility and the general health of patients.

查看原文本刊更多论文

宫腔镜切除治疗剖宫产瘢痕异位妊娠。

剖宫产疤痕妊娠（CSP）是一种异位妊娠，位于以前剖腹产疤痕的子宫肌层。这种情况很少见，但很危险。本研究的目的是介绍10例经宫腔镜切除治疗的CSP。在术前阶段，β -人绒毛膜促性腺激素（B-hCG）滴度大于10,000的患者使用甲氨蝶呤（MTX）治疗以降低B-hCG滴度。2例患者未接受甲氨蝶呤治疗。除1例患者因B-hCG未降低、剖宫产瘢痕部位无法修复、子宫穿孔最终行子宫切除术外，其余患者均行宫腔镜切除。所有患者月经周期正常，2个月后β-hCG水平均为阴性。3年后无复发报告。低侵入性治疗，如宫腔镜切除，是维持生育能力和患者整体健康的重要步骤。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊